Decheng Capital LLC Equillium, Inc. Transaction History
Decheng Capital LLC
- $356 Billion
- Q1 2025
A detailed history of Decheng Capital LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 4,447,308 shares of EQ stock, worth $1.47 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
4,447,308
Previous 4,447,308
-0.0%
Holding current value
$1.47 Million
Previous $3.33 Billion
47.57%
% of portfolio
0.49%
Previous 0.71%
Shares
1 transactions
Others Institutions Holding EQ
# of Institutions
27Shares Held
11.3MCall Options Held
13.2KPut Options Held
100-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$1.47 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$277,8420.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$185,551100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny270KShares$88,9350.0% of portfolio
-
Geode Capital Management, LLC Boston, MA205KShares$67,7710.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $11.3M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...